Bengaluru's Spread Design & Innovation studio clinches the prestigious Red Dot Award 2025 for its 'Imagination' project, celebrating ten years of groundbreaking work. Discover how this Indian firm is shaping the future of design.
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Indian pharmaceutical companies, long known for generics, saw their risky innovation bets yield major commercial success in 2025 through global deals and approvals. Discover the key players and what's next for 2026.
Bestselling authors unveil 'LeanSpark', a new framework turning scarcity into scalable, sustainable innovation. Discover how India's frugal model can inspire the world. Pre-order now!
IIT Hyderabad's third Innovation Day saw 1000+ participants. It launched RISE 2026, a national UG innovation meet with a ₹15 lakh prize pool, spotlighting India's future tech talent. Read more.
Union Health Minister JP Nadda unveiled the Indian Pharmacopoeia 2026, adding 121 new drug monographs to enhance drug quality and safety standards in India.
India sets a 2026 health roadmap focusing on stringent drug quality, TB elimination, obesity, and a ₹4,200 crore innovation push. Will execution match ambition?
JioHotstar's new series 'Pharma' ignites public debate on drug pricing, ethics, and accessibility in India's healthcare system. Read the full analysis.
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
Gujarat consolidates its position as a top startup hub with 16,700 operational ventures. Initiatives like i-Hub and WEStart fuel growth, creating 1,400 jobs. Discover the state's innovation strategy.
The Indian government is considering data exclusivity for pharma, a move that could delay cheap generic drugs, impact India's global edge, and affect medicine access. Read the full analysis.
US President Donald Trump secures agreements with nine major pharmaceutical companies to reduce Medicaid and cash-pay drug prices, aiming to align US costs with other wealthy nations. Details inside.
Kerala Startup Mission's Innovation Train will take young innovators from Thiruvananthapuram to Kasaragod, ideating grassroots solutions. Journey starts Dec 21. Read more.
Pfizer India and Cipla announce a 5-year partnership. Cipla will exclusively market and distribute four key Pfizer brands in India, aiming to expand patient reach nationwide. Read details.
AFCONS Infrastructure secures the prestigious CII Industrial Innovation Awards 2025 for its pioneering Digital Twin technology, marking a major leap in Indian construction innovation. Discover how they are transforming projects.
Himachal Pradesh govt introduces Minimum Import Price on potassium clavulanate & intermediates till Nov 2026 to shield Indian API makers from cheap Chinese imports. Read details.
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Zee Media's Global Innovation Leadership Summit 2025 in London strengthens India-UK economic collaboration, focusing on trade, innovation, and strategic partnerships. Explore the key outcomes.
The IIC Regional Meet 2025 in Raipur united 600 delegates to push for innovation hubs in higher education. Governor Ramen Deka urged converting ideas into scalable impact. Read more.
Granules India establishes two advanced research centres at IIT Hyderabad's Technology Research Park, focusing on peptide development and particle engineering to enhance global pharma innovation.
Mumbai's Wockhardt creates history as USFDA accepts its New Drug Application for antibiotic Zaynich, a first for an Indian firm. Shares surge 19%. Read more.
Wockhardt shares surged 19.3% after US FDA accepted its New Drug Application for Zaynich, a first-in-class antibiotic. This marks a historic first for an Indian pharma company's New Chemical Entity.
Hyderabad teacher SK Rajali Pasha develops innovative smart cap that vibrates at loud sounds, helping hearing impaired individuals stay safe on roads and workplaces. Read his inspiring story.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Infosys Foundation Trustee Sunil Kumar Dhareshwar emphasizes urgent need for serious social innovators to build vibrant ecosystem. Exclusive interview reveals future vision.
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.